He B - Search Results

1

SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.

Zhang Y, He J, Zhang F, Li H, Yue D, Wang C, Jablons DM, He B, Lui N. Zhang Y, et al. Among authors: he j, he b. J Exp Clin Cancer Res. 2013 Feb 5;32(1):7. doi: 10.1186/1756-9966-32-7. J Exp Clin Cancer Res. 2013. PMID: 23379358 Free PMC article.

2

Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.

Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM. Uematsu K, et al. Among authors: he b. Cancer Res. 2003 Aug 1;63(15):4547-51. Cancer Res. 2003. PMID: 12907630

3

Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.

You L, He B, Uematsu K, Xu Z, Mazieres J, Lee A, McCormick F, Jablons DM. You L, et al. Among authors: he b. Cancer Res. 2004 May 15;64(10):3474-8. doi: 10.1158/0008-5472.CAN-04-0115. Cancer Res. 2004. PMID: 15150100

4

Wnt2 as a new therapeutic target in malignant pleural mesothelioma.

Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM. Mazieres J, et al. Among authors: he b. Int J Cancer. 2005 Nov 1;117(2):326-32. doi: 10.1002/ijc.21160. Int J Cancer. 2005. PMID: 15900580

5

Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM. Batra S, et al. Among authors: he b. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1228-32. doi: 10.1016/j.bbrc.2006.02.084. Epub 2006 Feb 24. Biochem Biophys Res Commun. 2006. PMID: 16516163

6

Update on the molecular biology of malignant mesothelioma.

Lee AY, Raz DJ, He B, Jablons DM. Lee AY, et al. Among authors: he b. Cancer. 2007 Apr 15;109(8):1454-61. doi: 10.1002/cncr.22552. Cancer. 2007. PMID: 17348013 Free article. Review.

7

Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.

Mikami I, Zhang F, Hirata T, Okamoto J, Koizumi K, Shimizu K, Jablons D, He B. Mikami I, et al. Among authors: he b. Oncol Rep. 2010 Dec;24(6):1677-81. doi: 10.3892/or_00001033. Oncol Rep. 2010. PMID: 21042767

8

Gli as a novel therapeutic target in malignant pleural mesothelioma.

Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons DM, He B. Li H, et al. Among authors: he b. PLoS One. 2013;8(3):e57346. doi: 10.1371/journal.pone.0057346. Epub 2013 Mar 6. PLoS One. 2013. PMID: 23483902 Free PMC article.

9

Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.

Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, Shi H, Zhang H, Hao X, Wang C, Jablons DM, He B. Yue D, et al. Among authors: he b. J Exp Clin Cancer Res. 2014 Apr 24;33(1):34. doi: 10.1186/1756-9966-33-34. J Exp Clin Cancer Res. 2014. PMID: 24758269 Free PMC article.

10

The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.

Giroux Leprieur E, Hirata T, Mo M, Chen Z, Okamoto J, Clement G, Li H, Wislez M, Jablons DM, He B. Giroux Leprieur E, et al. Among authors: he b. Lung Cancer. 2014 Sep;85(3):465-71. doi: 10.1016/j.lungcan.2014.06.018. Epub 2014 Jun 30. Lung Cancer. 2014. PMID: 25023662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,990 results

Search Page

Filters